Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
暂无分享，去创建一个
M. Wood | Y. Lamberty | R. Kaminski | J. Hannestad | M. Gillard | H. Klitgaard | J. Nicolas | K. Leclercq | A. Matagne | Christian Wolff | M. De Ryck | B. Kenda | I. Niespodziany | Sophie Kervyn | Isabelle Niespodziany